Published in J Rheumatol on October 01, 1999
Validation of the ABILHAND questionnaire as a measure of manual ability in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 0.84
The impact of digit-related radiographic osteoarthritis of the hand on grip-strength and upper extremity disability. Clin Orthop Relat Res (2012) 0.79
The use of shoulder scoring systems and outcome measures in the UK. Ann R Coll Surg Engl (2014) 0.75
Patient-Reported Outcomes in Psoriatic Arthritis. Rheum Dis Clin North Am (2016) 0.75
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73
Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA (1995) 5.28
Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol (2000) 5.01
Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med (1998) 4.01
The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens (1999) 3.72
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
A role for jasmonate in pathogen defense of Arabidopsis. Proc Natl Acad Sci U S A (1998) 3.34
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA (1996) 2.98
When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol (2001) 2.84
Characterization of an antibiotic produced by a strain of Pseudomonas fluorescens inhibitory to Gaeumannomyces graminis var. tritici and Pythium spp. Antimicrob Agents Chemother (1986) 2.82
Contribution of phenazine antibiotic biosynthesis to the ecological competence of fluorescent pseudomonads in soil habitats. Appl Environ Microbiol (1992) 2.75
Psoriatic arthritis precipitated by physical trauma. J Rheumatol (1990) 2.70
Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum (1988) 2.62
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Ann Rheum Dis (2004) 2.47
Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum (1997) 2.40
PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem (2000) 2.26
Conservation of the 2,4-diacetylphloroglucinol biosynthesis locus among fluorescent Pseudomonas strains from diverse geographic locations. Appl Environ Microbiol (1996) 2.25
Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA (1996) 2.08
Methotrexate in systemic lupus erythematosus. J Rheumatol (1994) 2.08
Some issues for the biosafety protocol. Nature (1998) 2.06
Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum (2001) 2.04
'Oral hygiene'--a significant obstacle to dental health? Br Dent J (1994) 2.04
Vitamin D insufficiency in a large female SLE cohort. Lupus (2009) 2.02
A seven-gene locus for synthesis of phenazine-1-carboxylic acid by Pseudomonas fluorescens 2-79. J Bacteriol (1998) 1.94
Monitoring surgical performance using risk-adjusted cumulative sum charts. Biostatistics (2000) 1.85
Treatment recommendations for psoriatic arthritis. Ann Rheum Dis (2008) 1.85
Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.81
State accountability for wife-beating: the Indian challenge. Lancet (1997) 1.81
Making greater use of introduced microorganisms for biological control of plant pathogens. Annu Rev Phytopathol (1993) 1.77
Canadian Hemodialysis Morbidity Study. Am J Kidney Dis (1992) 1.72
Risk-adjusted monitoring of binary surgical outcomes. Med Decis Making (2001) 1.70
HLA antigens in psoriatic arthritis. J Rheumatol (1986) 1.69
The Westmead Head Injury Project outcome in severe head injury. A comparative analysis of pre-hospital, clinical and CT variables. Br J Neurosurg (1993) 1.64
Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost (2009) 1.63
Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus (2000) 1.59
Understanding clinical trials. BMJ (1994) 1.59
Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol (2000) 1.57
Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol (2001) 1.56
A decade of international change in abortion law: 1967-1977. Am J Public Health (1978) 1.53
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.52
How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.52
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol (1995) 1.52
Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol (1996) 1.50
Challenges of ethical research in resource-poor settings. Int J Gynaecol Obstet (2003) 1.50
Glycine N-methyltransferase is a folate binding protein of rat liver cytosol. Proc Natl Acad Sci U S A (1984) 1.49
The natural history of asymptomatic urolithiasis. J Urol (1992) 1.49
Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum (2009) 1.46
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann Rheum Dis (2008) 1.45
Neurologic changes during carotid endarterectomy under cervical block predict a high risk of postoperative stroke. Anesthesiology (1993) 1.44
Psoriatic arthritis and imaging. Ann Rheum Dis (2005) 1.44
The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol (1995) 1.43
Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis (2005) 1.42
Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. Biochem Biophys Res Commun (1985) 1.42
Adolescents and consent to treatment. Int J Gynaecol Obstet (2005) 1.42
Morbidity in systemic lupus erythematosus. J Rheumatol Suppl (1987) 1.41
Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol (2001) 1.40
Legal abortion: limits and contributions to human life. Ciba Found Symp (1985) 1.39
A double-blind assessment of segmental sensory changes with epidural fentanyl versus epidural saline in patients undergoing extracorporeal shock-wave lithotripsy. Anesthesiology (1990) 1.39
CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet (2003) 1.38
Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol (1997) 1.34
The lupus activity criteria count (LACC). J Rheumatol (1984) 1.34
Mifepristone (RU 486)--an abortifacient to prevent abortion? N Engl J Med (1992) 1.30
Systemic lupus erythematosus in males. Medicine (Baltimore) (1983) 1.29
Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol (1995) 1.29
Bacillus sp. L324-92 for Biological Control of Three Root Diseases of Wheat Grown with Reduced Tillage. Phytopathology (1997) 1.28
Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med (1985) 1.28
Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis (2007) 1.28
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum (1981) 1.27
Otitis externa infections related to Pseudomonas aeruginosa levels in five Ontario lakes. Can J Public Health (1984) 1.27
HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum (1992) 1.27
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus (2001) 1.26
Neuropsychiatric lupus. J Rheumatol (1980) 1.25
Impaired antigen-specific suppressor cell activity in psoriasis and psoriatic arthritis. J Invest Dermatol (1981) 1.23
Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol (1995) 1.23
Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver. Arch Biochem Biophys (1985) 1.23
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum (2007) 1.21
Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis (2005) 1.21
Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum (1994) 1.20
Lupus and pregnancy studies. Arthritis Rheum (1993) 1.20
Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med (1991) 1.20
Effects of fungal root pathogens on the population dynamics of biocontrol strains of fluorescent pseudomonads in the wheat rhizosphere. Appl Environ Microbiol (1991) 1.20
Radiological assessment in psoriatic arthritis. Br J Rheumatol (1998) 1.20
Malignancy in systemic lupus erythematosus. Arthritis Rheum (1996) 1.19
HLA markers and progression in psoriatic arthritis. J Rheumatol (1998) 1.18
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. J Rheumatol (1994) 1.17
Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol (1997) 1.17
Impact on agriculture of the mount st. Helens eruptions. Science (1981) 1.17
A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol (1995) 1.16
Systemic lupus erythematosus with negative LE cells and antinuclear factor. J Rheumatol (1978) 1.16
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am J Med (1979) 1.15
Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.14
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA. Ann Rheum Dis (2010) 1.12